ACTIVE SUBSTANCE / INN

OCRIPLASMIN

Brand name(s): Jetrea, JETREA
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
BLA125422
Retinal Diseases
ACTIVE SUBSTANCE
Ocriplasmin
REGULATORS
FDA · EMA
SPONSORS / MAH
Inceptua AB, THROMBOGENICS, INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
JETREABLA125422THROMBOGENICS, INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
JetreaInceptua ABWithdrawn13/03/2013Retinal Diseases

FULL INTELLIGENCE ON OCRIPLASMIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →